Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia
Cited by 0
Related Papers
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
|Nature Communications|2021|143
Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways
|Acta Pharmacologica Sinica|2020|41
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition
|Cell Death and Disease|2018|36
WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia
|Cancer Cell International|2019|33
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
|Cell Death and Disease|2021|19